Weighted Average Number of Shares Outstanding, Diluted of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. from 26 Jun 2010 to 27 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 26 Jun 2010 to 27 Dec 2025.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 27 Dec 2025 was 49,564,000, a 4% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 49,564,000, a 4% decline from 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 51,628,000, a 0.34% increase from 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51,451,000, a 0.29% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 49,564,000 -2,064,000 -4% 28 Sep 2025 27 Dec 2025 10-K 18 Feb 2026 2025 FY
Q3 2025 49,426,000 -2,157,000 -4.2% 29 Jun 2025 27 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 49,316,000 -2,530,000 -4.9% 30 Mar 2025 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 50,853,000 -989,000 -1.9% 29 Dec 2024 29 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 51,628,000 +177,000 +0.34% 29 Sep 2024 28 Dec 2024 10-K 18 Feb 2026 2025 FY
Q3 2024 51,583,000 -24,000 -0.05% 30 Jun 2024 28 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 51,846,000 +379,000 +0.74% 31 Mar 2024 29 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 51,842,000 +414,000 +0.8% 31 Dec 2023 30 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 51,451,000 +150,000 +0.29% 01 Oct 2023 30 Dec 2023 10-K 18 Feb 2026 2025 FY
Q3 2023 51,607,000 +324,000 +0.63% 02 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 51,467,000 +184,000 +0.36% 02 Apr 2023 01 Jul 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 51,428,000 +103,000 +0.2% 01 Jan 2023 01 Apr 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 51,301,000 -124,000 -0.24% 25 Sep 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
Q3 2022 51,283,000 -275,000 -0.53% 26 Jun 2022 24 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 51,283,000 -51,000 -0.1% 27 Mar 2022 25 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 51,325,000 +250,000 +0.49% 26 Dec 2021 26 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 51,425,000 +814,000 +1.6% 26 Sep 2021 25 Dec 2021 10-K 14 Feb 2024 2023 FY
Q3 2021 51,558,000 +856,000 +1.7% 27 Jun 2021 25 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 51,334,000 +1,088,000 +2.2% 28 Mar 2021 26 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 51,075,000 +1,109,000 +2.2% 27 Dec 2020 27 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 50,611,000 +918,000 +1.8% 27 Sep 2020 26 Dec 2020 10-K 22 Feb 2023 2022 FY
Q3 2020 50,702,000 +987,000 +2% 28 Jun 2020 26 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 50,246,000 +584,000 +1.2% 29 Mar 2020 27 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 49,966,000 +504,000 +1% 29 Dec 2019 28 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 49,693,000 +675,000 +1.4% 29 Sep 2019 28 Dec 2019 10-K 16 Feb 2022 2021 FY
Q3 2019 49,715,000 +389,000 +0.79% 30 Jun 2019 28 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 49,662,000 +619,000 +1.3% 31 Mar 2019 29 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 49,462,000 +634,000 +1.3% 30 Dec 2018 30 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 49,018,000 +454,000 +0.94% 30 Sep 2018 29 Dec 2018 10-K 17 Feb 2021 2020 FY
Q3 2018 49,326,000 +936,000 +1.9% 01 Jul 2018 29 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 49,043,000 +701,000 +1.4% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019 2019 Q2
Q1 2018 48,828,000 +407,000 +0.84% 31 Dec 2017 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 48,564,000 +606,000 +1.3% 01 Oct 2017 30 Dec 2017 10-K 11 Feb 2020 2019 FY
Q3 2017 48,390,000 +356,000 +0.74% 02 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 48,342,000 +423,000 +0.88% 02 Apr 2017 01 Jul 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 48,421,000 +804,000 +1.7% 01 Jan 2017 01 Apr 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 47,958,000 +324,000 +0.68% 25 Sep 2016 31 Dec 2016 10-K 13 Feb 2019 2018 FY
Q3 2016 48,034,000 +789,000 +1.7% 26 Jun 2016 24 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 47,919,000 +369,000 +0.78% 27 Mar 2016 25 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 47,617,000 -251,000 -0.52% 27 Dec 2015 26 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 47,634,000 +76,000 +0.16% 27 Sep 2015 26 Dec 2015 10-K 13 Feb 2018 2017 FY
Q3 2015 47,245,000 +367,000 +0.78% 28 Jun 2015 26 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 47,550,000 -134,000 -0.28% 29 Mar 2015 27 Jun 2015 10-Q 03 Aug 2016 2016 Q2
Q1 2015 47,868,000 -283,000 -0.59% 28 Dec 2014 28 Mar 2015 10-Q 04 May 2016 2016 Q1
Q4 2014 47,558,000 -931,322 -1.9% 28 Sep 2014 27 Dec 2014 10-K 14 Feb 2017 2016 FY
Q3 2014 46,878,000 -1,563,165 -3.2% 29 Jun 2014 27 Sep 2014 10-Q 04 Nov 2015 2015 Q3
Q2 2014 47,684,000 -1,151,453 -2.4% 30 Mar 2014 28 Jun 2014 10-Q 30 Jul 2015 2015 Q2
Q1 2014 48,151,000 -285,049 -0.59% 29 Dec 2013 29 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q4 2013 48,489,322 +83,002 +0.17% 29 Sep 2013 28 Dec 2013 10-K 25 Feb 2014 2013 FY
Q3 2013 48,441,165 +332,551 +0.69% 30 Jun 2013 28 Sep 2013 10-Q 30 Oct 2014 2014 Q3
Q2 2013 48,835,453 +422,653 +0.87% 31 Mar 2013 29 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 48,436,049 -335,694 -0.69% 30 Dec 2012 30 Mar 2013 10-Q 30 Apr 2014 2014 Q1
Q4 2012 48,406,320 -2,911,922 -5.7% 30 Sep 2012 29 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 48,108,614 -2,425,133 -4.8% 01 Jul 2012 29 Sep 2012 10-Q 30 Oct 2013 2013 Q3
Q2 2012 48,412,800 -3,267,937 -6.3% 01 Apr 2012 30 Jun 2012 10-Q 31 Jul 2013 2013 Q2
Q1 2012 48,771,743 -5,825,997 -11% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q4 2011 51,318,242 25 Sep 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
Q3 2011 50,533,747 -12,063,308 -19% 26 Jun 2011 24 Sep 2011 10-Q 01 Nov 2012 2012 Q3
Q2 2011 51,680,737 -14,193,547 -22% 27 Mar 2011 25 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 54,597,740 26 Dec 2010 26 Mar 2011 10-Q 04 May 2012 2012 Q1
Q3 2010 62,597,055 27 Jun 2010 25 Sep 2010 10-Q 02 Nov 2011 2011 Q3
Q2 2010 65,874,284 28 Mar 2010 26 Jun 2010 10-Q 03 Aug 2011 2011 Q2

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 49,564,000 -2,064,000 -4% 29 Dec 2024 27 Dec 2025 10-K 18 Feb 2026 2025 FY
2024 51,628,000 +177,000 +0.34% 31 Dec 2023 28 Dec 2024 10-K 18 Feb 2026 2025 FY
2023 51,451,000 +150,000 +0.29% 01 Jan 2023 30 Dec 2023 10-K 18 Feb 2026 2025 FY
2022 51,301,000 -124,000 -0.24% 26 Dec 2021 31 Dec 2022 10-K 19 Feb 2025 2024 FY
2021 51,425,000 +814,000 +1.6% 27 Dec 2020 25 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 50,611,000 +918,000 +1.8% 29 Dec 2019 26 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 49,693,000 +675,000 +1.4% 30 Dec 2018 28 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 49,018,000 +454,000 +0.94% 31 Dec 2017 29 Dec 2018 10-K 17 Feb 2021 2020 FY
2017 48,564,000 +606,000 +1.3% 01 Jan 2017 30 Dec 2017 10-K 11 Feb 2020 2019 FY
2016 47,958,000 +324,000 +0.68% 27 Dec 2015 31 Dec 2016 10-K 13 Feb 2019 2018 FY
2015 47,634,000 +76,000 +0.16% 28 Dec 2014 26 Dec 2015 10-K 13 Feb 2018 2017 FY
2014 47,558,000 -931,322 -1.9% 29 Dec 2013 27 Dec 2014 10-K 14 Feb 2017 2016 FY
2013 48,489,322 +83,002 +0.17% 30 Dec 2012 28 Dec 2013 10-K 25 Feb 2014 2013 FY
2012 48,406,320 -2,911,922 -5.7% 01 Jan 2012 29 Dec 2012 10-K 25 Feb 2014 2013 FY
2011 51,318,242 -11,243,052 -18% 26 Dec 2010 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 62,561,294 27 Dec 2009 25 Dec 2010 10-K 27 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.